RÉSUMÉ
Increasing gold and mineral mining activity in rivers across the global tropics has degraded ecosystems and threatened human health1,2. Such river mineral mining involves intensive excavation and sediment processing in river corridors, altering river form and releasing excess sediment downstream2. Increased suspended sediment loads can reduce water clarity and cause siltation to levels that may result in disease and mortality in fish3,4, poor water quality5 and damage to human infrastructure6. Although river mining has been investigated at local scales, no global synthesis of its physical footprint and impacts on hydrologic systems exists, leaving its full environmental consequences unknown. We assemble and analyse a 37-year satellite database showing pervasive, increasing river mineral mining worldwide. We identify 396 mining districts in 49 countries, concentrated in tropical waterways that are almost universally altered by mining-derived sediment. Of 173 mining-affected rivers, 80% have suspended sediment concentrations (SSCs) more than double pre-mining levels. In 30 countries in which mining affects large (>50 m wide) rivers, 23 ± 19% of large river length is altered by mining-derived sediment, a globe-spanning effect representing 35,000 river kilometres, 6% (±1% s.e.) of all large tropical river reaches. Our findings highlight the ubiquity and intensity of mining-associated degradation in tropical river systems.
Sujet(s)
Écosystème , Sédiments géologiques , Mine , Rivières , Climat tropical , Animaux , Humains , Bases de données factuelles , Or , Hydrologie , Mine/statistiques et données numériques , Mine/tendances , Poissons , Sédiments géologiques/analyseRÉSUMÉ
A novel function for the L1 cell adhesion molecule, which binds the actin adaptor protein Ankyrin was identified in constraining dendritic spine density on pyramidal neurons in the mouse neocortex. In an L1-null mouse mutant increased spine density was observed on apical but not basal dendrites of pyramidal neurons in diverse cortical areas (prefrontal cortex layer 2/3, motor cortex layer 5, visual cortex layer 4. The Ankyrin binding motif (FIGQY) in the L1 cytoplasmic domain was critical for spine regulation, as demonstrated by increased spine density and altered spine morphology in the prefrontal cortex of a mouse knock-in mutant (L1YH) harboring a tyrosine (Y) to histidine (H) mutation in the FIGQY motif, which disrupted L1-Ankyrin association. This mutation is a known variant in the human L1 syndrome of intellectual disability. L1 was localized by immunofluorescence staining to spine heads and dendrites of cortical pyramidal neurons. L1 coimmunoprecipitated with Ankyrin B (220 kDa isoform) from lysates of wild type but not L1YH forebrain. This study provides insight into the molecular mechanism of spine regulation and underscores the potential for this adhesion molecule to regulate cognitive and other L1-related functions that are abnormal in the L1 syndrome.
RÉSUMÉ
It has widely been thought that in the process of nerve regeneration Schwann cells populate the injury site with myelinating, non-myelinating, phagocytic, repair, and mesenchyme-like phenotypes. It is now clear that the Schwann cells modify their shape and basal lamina as to accommodate re-growing axons, at the same time clear myelin debris generated upon injury, and regulate expression of extracellular matrix proteins at and around the lesion site. Such a remarkable plasticity may follow an intrinsic functional rhythm or a systemic circadian clock matching the demands of accurate timing and precision of signalling cascades in the regenerating nervous system. Schwann cells react to changes in the external circadian clock clues and to the Zeitgeber hormone melatonin by altering their plasticity. This raises the question of whether melatonin regulates Schwann cell activity during neurorepair and if circadian control and rhythmicity of Schwann cell functions are vital aspects of neuroregeneration. Here, we have focused on different schools of thought and emerging concepts of melatonin-mediated signalling in Schwann cells underlying peripheral nerve regeneration and discuss circadian rhythmicity as a possible component of neurorepair.
RÉSUMÉ
The neuronal cell adhesion and recognition molecule L1 does not only 'keep cells together' by way of homophilic and heterophilic interactions, but can also promote cell motility when cleaved into fragments by several proteases. It has largely been thought that such fragments are signs of degradation. Now, it is clear that proteolysis contributes to the pronounced functional diversity of L1, which we have reviewed in this work. L1 fragments generated at the plasma membrane are released into the extracellular space, whereas other membrane-bound fragments are internalised and enter the nucleus, thus conveying extracellular signals to the cell interior. Post-translational modifications on L1 determine the sequence of cleavage by proteases and the subcellular localisation of the generated fragments. Inside the neuronal cells, L1 fragments interact with various binding partners to facilitate morphogenic events, as well as regenerative processes. The stimulation of L1 proteolysis via injection of L1 peptides or proteases active on L1 or L1 mimetics is a promising tool for therapy of injured nervous systems. The collective findings gathered over the years not only shed light on the great functional diversity of L1 and its fragments, but also provide novel mechanistic insights into the adhesion molecule proteolysis that is active in the developing and diseased nervous system.
Sujet(s)
Molécule d'adhérence cellulaire neurale L-1 , Adhérence cellulaire , Molécule d'adhérence cellulaire neurale L-1/composition chimique , Molécule d'adhérence cellulaire neurale L-1/métabolisme , Peptide hydrolases/métabolisme , Peptides/métabolisme , ProtéolyseRÉSUMÉ
Dissociation of hyper-phosphorylated Tau from neuronal microtubules and its pathological aggregates, are hallmarks in the etiology of tauopathies. The Tau-microtubule interface is subject to polyglutamylation, a reversible posttranslational modification, increasing negative charge at tubulin C-terminal tails. Here, we asked whether tubulin polyglutamylation may contribute to Tau pathology in vivo. Since polyglutamylases modify various proteins other than tubulin, we generated a knock-in mouse carrying gene mutations to abolish Tuba4a polyglutamylation in a substrate-specific manner. We found that Tuba4a lacking C-terminal polyglutamylation prevents the binding of Tau and GSK3 kinase to neuronal microtubules, thereby strongly reducing phospho-Tau levels. Notably, crossbreeding of the Tuba4a knock-in mouse with the hTau tauopathy model, expressing a human Tau transgene, reversed hyper-phosphorylation and oligomerization of Tau and normalized microglia activation in brain. Our data highlight tubulin polyglutamylation as a potential therapeutic strategy in fighting tauopathies.
Sujet(s)
Tauopathies , Tubuline , Animaux , Glycogen Synthase Kinase 3/métabolisme , Humains , Souris , Microglie/métabolisme , Microtubules/métabolisme , Phosphorylation , Tauopathies/métabolisme , Tubuline/génétique , Tubuline/métabolisme , Protéines tau/génétique , Protéines tau/métabolismeRÉSUMÉ
The nature of brain impairment after hypoxia is complex and recovery harnesses different mechanisms, including neuroprotection and neurogenesis. Experimental evidence suggests that hypoxia may trigger neurogenesis postnatally by influencing the expression of a variety of transcription factors. However, the existing data are controversial. As a proof-of-principle, we subjected cultured cerebral cortex neurons, cerebellar granule neurons and organotypic cerebral cortex slices from rat brains to hypoxia and treated these cultures with the hormone ghrelin, which is well-known for its neuroprotective functions. We found that hypoxia elevated the expression levels and stimulated nuclear translocation of ghrelin's receptor GHSR1 in the cultured neurons and the acute organotypic slices, whereas ghrelin treatment reduced the receptor expression to normoxic levels. GHSR1 expression was also increased in cerebral cortex neurons of mice with induced experimental stroke. Additional quantitative analyses of immunostainings for neuronal proliferation and differentiation markers revealed that hypoxia stimulated the proliferation of neuronal progenitors, whereas ghrelin application during the phase of recovery from hypoxia counteracted these effects. At the mechanistic level, we provide a link between the described post-ischemic phenomena and the expression of the transcription factor Pax6, an important regulator of neural progenitor cell fate. In contrast to the neurogenic niches in the brain where hypoxia is known to increase Pax6 expression, the levels of the transcription factor in cultured hypoxic cerebral cortex cells were downregulated. Moreover, the application of ghrelin to hypoxic neurons normalised the expression levels of these factors. Our findings suggest that ghrelin stimulates neurogenic factors for the protection of neurons in a GHSR1-dependent manner in non-neurogenic brain areas such as the cerebral cortex after exposure to hypoxia.
Sujet(s)
Ghréline , Cellules souches neurales , Animaux , Encéphale/métabolisme , Ghréline/métabolisme , Ghréline/pharmacologie , Hypoxie/métabolisme , Souris , Cellules souches neurales/métabolisme , Neurones/métabolisme , Facteur de transcription PAX6/génétique , Facteur de transcription PAX6/métabolisme , Rats , Facteurs de transcription/métabolismeRÉSUMÉ
The role that the immune system plays after injury of the peripheral nervous system is still not completely understood. Perforin, a natural killer cell- and T-lymphocyte-derived enzyme that mediates cytotoxicity, plays important roles in autoimmune diseases, infections and central nervous system trauma, such as spinal cord injury. To dissect the roles of this single component of the immune response to injury, we tested regeneration after femoral nerve injury in perforin-deficient (Pfp-/-) and wild-type control mice. Single frame motion analysis showed better motor recovery in Pfp-/- mice compared with control mice at 4 and 8 weeks after injury. Retrograde tracing of the motoneuron axons regrown into the motor nerve branch demonstrated more correctly projecting motoneurons in the spinal cord of Pfp-/- mice compared with wild-types. Myelination of regrown axons measured by g-ratio was more extensive in Pfp-/- than in wild-type mice in the motor branch of the femoral nerve. Pfp-/- mice displayed more cholinergic synaptic terminals around cell bodies of spinal motoneurons after injury than the injured wild-types. We histologically analyzed lymphocyte infiltration 10 days after surgery and found that in Pfp-/- mice the number of lymphocytes in the regenerating nerves was lower than in wild-types, suggesting a closed blood-nerve barrier in Pfp-/- mice. We conclude that perforin restricts motor recovery after femoral nerve injury owing to decreased survival of motoneurons and reduced myelination.
RÉSUMÉ
The nervous system is highly vulnerable to different factors which may cause injury followed by an acute or chronic neurodegeneration. Injury involves a loss of extracellular matrix integrity, neuronal circuitry disintegration, and impairment of synaptic activity and plasticity. Application of pleiotropic molecules initiating extracellular matrix reorganization and stimulating neuronal plasticity could prevent propagation of the degeneration into the tissue surrounding the injury. To find an omnipotent therapeutic molecule, however, seems to be a fairly ambitious task, given the complex demands of the regenerating nervous system that need to be fulfilled. Among the vast number of candidates examined so far, the neuropeptide and hormone ghrelin holds within a very promising therapeutic potential with its ability to cross the blood-brain barrier, to balance metabolic processes, and to stimulate neurorepair and neuroactivity. Compared with its well-established systemic effects in treatment of metabolism-related disorders, the therapeutic potential of ghrelin on neuroregeneration upon injury has received lesser appreciation though. Here, we discuss emerging concepts of ghrelin as an omnipotent player unleashing developmentally related molecular cues and morphogenic cascades, which could attenuate and/or counteract acute and chronic neurodegeneration.
RÉSUMÉ
L1 syndrome is a rare developmental disorder characterized by hydrocephalus of varying severity, intellectual deficits, spasticity of the legs, and adducted thumbs. Therapy is limited to symptomatic relief. Numerous gene mutations in the L1 cell adhesion molecule (L1CAM, hereafter abbreviated L1) were identified in L1 syndrome patients, and those affecting the extracellular domain of this transmembrane type 1 glycoprotein show the most severe phenotypes. Previously analyzed rodent models of the L1 syndrome focused on L1-deficient animals or mouse mutants with abrogated cell surface expression of L1, making it difficult to test L1 function-triggering mimetic compounds with potential therapeutic value. To overcome this impasse, we generated a novel L1 syndrome mouse with a mutation of aspartic acid at position 201 in the extracellular part of L1 (p.D201N, hereafter termed L1-201) that displays a cell surface-exposed L1 accessible to the L1 mimetics. Behavioral assessment revealed an increased neurological deficit score and increased locomotor activity in male L1-201 mice carrying the mutation on the X-chromosome. Histological analyses of L1-201 mice showed features of the L1 syndrome, including enlarged ventricles and reduced size of the corpus callosum. Expression levels of L1-201 protein as well as extent of cell surface biotinylation and immunofluorescence labelling of cultured cerebellar neurons were normal. Importantly, treatment of these cultures with the L1 mimetic compounds duloxetine, crotamiton, and trimebutine rescued impaired cell migration and survival as well as neuritogenesis. Altogether, the novel L1 syndrome mouse model provides a first experimental proof-of-principle for the potential therapeutic value of L1 mimetic compounds.
Sujet(s)
Maladies génétiques liées au chromosome X/traitement médicamenteux , Déficience intellectuelle/traitement médicamenteux , Molécule d'adhérence cellulaire neurale L-1/métabolisme , Peptidomimétiques/usage thérapeutique , Paraplégie spasmodique héréditaire/traitement médicamenteux , Animaux , Cellules cultivées , Cervelet/cytologie , Cervelet/métabolisme , Cervelet/anatomopathologie , Ventricules cérébraux/métabolisme , Ventricules cérébraux/anatomopathologie , Corps calleux/métabolisme , Corps calleux/anatomopathologie , Chlorhydrate de duloxétine/pharmacologie , Chlorhydrate de duloxétine/usage thérapeutique , Maladies génétiques liées au chromosome X/génétique , Maladies génétiques liées au chromosome X/anatomopathologie , Déficience intellectuelle/génétique , Déficience intellectuelle/anatomopathologie , Locomotion , Mâle , Souris , Souris de lignée C57BL , Mutation , Molécule d'adhérence cellulaire neurale L-1/génétique , Neurogenèse , Neurones/effets des médicaments et des substances chimiques , Neurones/métabolisme , Peptidomimétiques/pharmacologie , Phénotype , Paraplégie spasmodique héréditaire/génétique , Paraplégie spasmodique héréditaire/anatomopathologie , Toluidines/pharmacologie , Toluidines/usage thérapeutique , Trimébutine/pharmacologie , Trimébutine/usage thérapeutiqueRÉSUMÉ
Reelin is a protein that is best known for its role in controlling neuronal layer formation in the developing cortex. Here, we studied its role for post-natal cortical network function, which is poorly explored. To preclude early cortical migration defects caused by Reelin deficiency, we used a conditional Reelin knock-out (RelncKO ) mouse, and induced Reelin deficiency post-natally. Induced Reelin deficiency caused hyperexcitability of the neocortical network in vitro and ex vivo. Blocking Reelin binding to its receptors ApoER2 and VLDLR resulted in a similar effect. Hyperexcitability in RelncKO organotypic slice cultures could be rescued by co-culture with wild-type organotypic slice cultures. Moreover, the GABAB receptor (GABAB R) agonist baclofen failed to activate and the antagonist CGP35348 failed to block GABAB Rs in RelncKO mice. Immunolabeling of RelncKO cortical slices revealed a reduction in GABAB R1 and GABAB R2 surface expression at the plasma membrane and western blot of RelncKO cortical tissue revealed decreased phosphorylation of the GABAB R2 subunit at serine 892 and increased phosphorylation at serine 783, reflecting receptor deactivation and proteolysis. These data show a role of Reelin in controlling early network activity, by modulating GABAB R function. Cover Image for this issue: https://doi.org/10.1111/jnc.15054.
Sujet(s)
Molécules d'adhérence cellulaire neuronale/déficit , Protéines de la matrice extracellulaire/déficit , Néocortex/métabolisme , Protéines de tissu nerveux/déficit , Récepteurs GABA-B/physiologie , Serine endopeptidases/déficit , Transduction du signal/physiologie , Animaux , Animaux nouveau-nés , Molécules d'adhérence cellulaire neuronale/génétique , Protéines de la matrice extracellulaire/génétique , Femelle , Agonistes du recepteur GABA-B/pharmacologie , Mâle , Souris , Souris knockout , Protéines de tissu nerveux/génétique , Techniques de culture d'organes , Protéine reeline , Serine endopeptidases/génétique , Transduction du signal/effets des médicaments et des substances chimiquesRÉSUMÉ
The important functions of cell adhesion molecule L1 in the nervous system depend on diverse proteolytic enzymes which generate different L1 fragments. It has been reported that cleavage in the third fibronectin type III (FNIII) homologous domain generates the fragments L1-80 and L1-140, while cleavage in the first FNIII domain yields the fragments L1-70 and L1-135. These results raised questions concerning the L1 cleavage sites. We thus generated gene-edited mice expressing L1 with mutations of the cleavage sites either in the first or third FNIII domain. By immunoprecipitations and immunoblot analyses using brain homogenates and different L1 antibodies, we show that L1-70 and L1-135 are generated in wild-type mice, but not or only to a low extent in L1 mutant mice. L1-80 and L1-140 were not detected in wild-type or mutant mice. Mass spectrometry confirmed the results from immunoprecipitations and immunoblot analyses. Based on these observations, we propose that L1-70 and L1-135 are the predominant fragments in the mouse nervous system and that the third FNIII domain is decisive for generating these fragments. Treatment of cultured cerebellar neurons with trypsin or plasmin, which were both proposed to generate L1-80 and L1-140 by cleaving in the third FNIII domain, showed by immunoprecipitations and immunoblot analyses that both proteases lead to the generation of L1-70 and L1-135, but not L1-80 and L1-140. We discuss previous observations on the basis of our new results and propose a novel view on the molecular features that render previous and present observations compatible.
Sujet(s)
Encéphale/métabolisme , Molécule d'adhérence cellulaire neurale L-1/métabolisme , Neurones/métabolisme , Protéolyse , Animaux , Souris , Souches mutantes de sourisRÉSUMÉ
Presynaptic mitochondrial Ca2+ plays a critical role in the regulation of synaptic transmission and plasticity. The presynaptic bouton of the hippocampal mossy fiber (MF) is much larger in size than that of the Schaffer collateral (SC) synapse. Here we compare the structural and physiological characteristics of MF and SC presynaptic boutons to reveal functional and mechanistic differences between these two synapses. Our quantitative ultrastructural analysis using electron microscopy show many more mitochondria in MF presynaptic bouton cross-section profiles compared to SC boutons. Consistent with these results, post-tetanic potentiation (PTP), a form of presynaptic short-term plasticity dependent on mitochondrial Ca2+, is reduced by inhibition of mitochondrial Ca2+ release at MF synapses but not at SC synapses. However, blockade of mitochondrial Ca2+ release results in reduction of PTP at SC synapses by disynaptic MF stimulation. Furthermore, inhibition of mitochondrial Ca2+ release selectively decreases frequency facilitation evoked by short trains of presynaptic stimulation at MF synapses, while having no effect at SC synapses. Moreover, depletion of ER Ca2+ stores leads to reduction of PTP at MF synapses, but PTP is unaffected by ER Ca2+ depletion at SC synapses. These findings show that MF and SC synapses differ in presynaptic mitochondrial content as well as mitochondrial Ca2+ dependent synaptic plasticity, highlighting differential regulatory mechanisms of presynaptic plasticity at MF and SC synapses.
Sujet(s)
Calcium/métabolisme , Hippocampe/métabolisme , Fibres moussues de l'hippocampe/métabolisme , Plasticité neuronale/physiologie , Animaux , Signalisation calcique/effets des médicaments et des substances chimiques , Signalisation calcique/physiologie , Potentiels post-synaptiques excitateurs/effets des médicaments et des substances chimiques , Potentiels post-synaptiques excitateurs/physiologie , Hippocampe/cytologie , Hippocampe/effets des médicaments et des substances chimiques , Hippocampe/ultrastructure , Mâle , Souris , Microscopie électronique , Mitochondries/effets des médicaments et des substances chimiques , Mitochondries/métabolisme , Fibres moussues de l'hippocampe/effets des médicaments et des substances chimiques , Fibres moussues de l'hippocampe/ultrastructure , Plasticité neuronale/effets des médicaments et des substances chimiques , Composés onium/pharmacologie , Composés organiques du phosphore/pharmacologie , Techniques de patch-clamp , Thiazépines/pharmacologieRÉSUMÉ
Proteolytic cleavage of the cell adhesion molecule L1 (L1) in brain tissue and in cultured cerebellar neurons results in the generation and nuclear import of a 30 kDa fragment comprising most of L1's C-terminal, intracellular domain. In search of molecules that interact with this domain, we performed affinity chromatography with the recombinant intracellular L1 domain and a nuclear extract from mouse brains, and identified potential nuclear L1 binding partners involved in transcriptional regulation, RNA processing and transport, DNA repair, chromatin remodeling, and nucleocytoplasmic transport. By co-immunoprecipitation and enzyme-linked immunosorbent assay using recombinant proteins, we verified the direct interaction between L1 and the nuclear binding partners non-POU domain containing octamer-binding protein and splicing factor proline/glutamine-rich. The proximity ligation assay confirmed this close interaction in cultures of cerebellar granule cells. Our findings suggest that L1 fragments regulate multiple nuclear functions in the nervous system. We discuss possible physiological and pathological roles of these interactions in regulation of chromatin structure, gene expression, RNA processing, and DNA repair.
Sujet(s)
Noyau de la cellule/métabolisme , Cytoplasme/métabolisme , Molécule d'adhérence cellulaire neurale L-1/physiologie , Neurones/métabolisme , Protéines nucléaires/métabolisme , Transport nucléaire actif , Animaux , Femelle , Mâle , Souris , Souris de lignée C57BL , Souris knockout , Liaison aux protéines , Domaines protéiquesRÉSUMÉ
In recent years, rising gold prices have exacerbated the global proliferation of artisanal-scale gold mining (ASGM), with catastrophic consequences for human and ecological health. Much of this burgeoning industry has occurred in biodiversity hot spots, notably in the tropical forests of South America. While the loss of tropical forests and floodplains as a result of ASGM has been well characterized, ASGM impacts on riverine hydrological properties are less understood. Previous fieldwork on ASGM-affected and gully-eroded tropical streams and rivers has demonstrated that increases in suspended-sediment concentration (SSC) can substantially impact fish diversity and aquatic community structure, yet our understanding of the timing and scope of impacts of such increases is limited by the lack of long-term records of SSC. To address this challenge, we present a 34-y analysis of the direct effect of ASGM on 32 river reaches in the Madre de Dios region of Peru, which has been heavily impacted by ASGM since the 1980s. We evaluate spatial and temporal patterns of impacts using estimated SSC derived from Landsat satellite imagery. We find that 16 of 18 stretches of river impacted by ASGM show significant increasing trends in SSC (P < 0.05), while only 5 of 14 unaffected sites do so. Additionally, ASGM appears to reverse natural seasonal cycles of SSC, which may imperil aquatic species. Overall, our findings indicate that ASGM is fundamentally altering optical water quality dynamics of a critical tropical biodiversity hot spot and provide guidance for future regulation of these activities.
RÉSUMÉ
Microtubule severing regulates cytoskeletal rearrangement underlying various cellular functions. Katanin, a heterodimer, consisting of catalytic (p60) and regulatory (p80) subunits severs dynamic microtubules to modulate several stages of cell division. The role of p60 katanin in the mammalian brain with respect to embryonic and adult neurogenesis is poorly understood. Here, we generated a Katna1 knockout mouse and found that consistent with a critical role of katanin in mitosis, constitutive homozygous Katna1 depletion is lethal. Katanin p60 haploinsufficiency induced an accumulation of neuronal progenitors in the subventricular zone during corticogenesis, and impaired their proliferation in the adult hippocampus dentate gyrus (DG) subgranular zone. This did not compromise DG plasticity or spatial and contextual learning and memory tasks employed in our study, consistent with the interpretation that adult neurogenesis may be associated with selective forms of hippocampal-dependent cognitive processes. Our data identify a critical role for the microtubule-severing protein katanin p60 in regulating neuronal progenitor proliferation in vivo during embryonic development and adult neurogenesis.
Sujet(s)
Différenciation cellulaire , Katanine/génétique , Microtubules/métabolisme , Cellules souches neurales/cytologie , Cellules souches neurales/métabolisme , Neurogenèse , Facteurs âges , Allèles , Animaux , Différenciation cellulaire/génétique , Prolifération cellulaire , Cortex cérébral/embryologie , Cortex cérébral/métabolisme , Gyrus denté/embryologie , Gyrus denté/métabolisme , Ciblage de gène , Haploinsuffisance , Katanine/métabolisme , Apprentissage , Mémoire , Souris , Souris knockout , Neurogenèse/génétique , Neurones/cytologie , Neurones/métabolisme , Organogenèse , PhénotypeRÉSUMÉ
The present study combines in utero transduction with transmission electron microscopy (TEM) aiming at a precise morphometrical analysis of ultrastructural parameters in unambiguously identified topographical structures, affected by a protein of interest that is introduced into the organism via viral transfer. This combined approach allows for a smooth transition from macrostructural to ultrastructural identification by following topographical navigation maps in a tissue atlas. High-resolution electron microscopy of the in-utero-transduced tissue reveals the fine ultrastructure of the neuropil and its plasticity parameters, such as cross-sectioned synaptic bouton areas, the number of synaptic vesicles and mitochondria within a bouton profile, the length of synaptic contacts, cross-sectioned axonal areas, the thickness of myelin sheaths, the number of myelin lamellae, and cross-sectioned areas of mitochondria profiles. The analysis of these parameters reveals essential insights into changes of ultrastructural plasticity in the areas of the nervous system that are affected by the viral transfer of the genetic construct. This combined method can not only be used for studying the direct effect of genetically engineered biomolecules and/or drugs on neuronal plasticity but also opens the possibility to study the in utero rescue of neuronal plasticity (e.g., in the context of neurodegenerative diseases).
Sujet(s)
Encéphale/ultrastructure , Plasticité neuronale/génétique , Moelle spinale/ultrastructure , Animaux , Femelle , Souris , GrossesseRÉSUMÉ
Typical Rho GTPases, such as Rac1, Cdc42, and RhoA, act as molecular switches regulating various aspects of platelet cytoskeleton reorganization. The loss of these enzymes results in reduced platelet functionality. Atypical Rho GTPases of the RhoBTB subfamily are characterized by divergent domain architecture. One family member, RhoBTB3, is expressed in platelets, but its function is unclear. In the present study we examined the role of RhoBTB3 in platelet function using a knockout mouse model. We found the platelet count, size, numbers of both alpha and dense granules, and surface receptor profile in these mice were comparable to wild-type mice. Deletion of Rhobtb3 had no effect on aggregation and dense granule secretion in response to a range of agonists including thrombin, collagen, and adenosine diphosphate (ADP). By contrast, alpha-granule secretion increased in mice lacking RhoBTB3 in response to thrombin, collagen related peptide (CRP) and U46619/ADP. Integrin activation and spreading on fibrinogen and collagen under static conditions were also unimpaired; however, we observed reduced platelet accrual on collagen under flow conditions. These defects did not translate into alterations in tail bleeding time. We conclude that genetic deletion of Rhobtb3 leads to subtle alterations in alpha-granule secretion and adhesion to collagen without significant effects on hemostasis in vivo.
Sujet(s)
Plaquettes/métabolisme , Collagène/pharmacologie , Granulations cytoplasmiques/métabolisme , Adhésivité plaquettaire , Rhéologie , Protéines G rho/déficit , Animaux , Plaquettes/effets des médicaments et des substances chimiques , Plaquettes/ultrastructure , Lignée cellulaire , Granulations cytoplasmiques/effets des médicaments et des substances chimiques , Humains , Mégacaryocytes/effets des médicaments et des substances chimiques , Mégacaryocytes/métabolisme , Souris de lignée C57BL , Souris knockout , Adhésivité plaquettaire/effets des médicaments et des substances chimiques , Agrégation plaquettaire/effets des médicaments et des substances chimiques , Complexe glycoprotéique IIb-IIIa de la membrane plaquettaire/métabolisme , ARN messager/génétique , ARN messager/métabolisme , Protéines G rho/génétique , Protéines G rho/métabolismeRÉSUMÉ
[This corrects the article DOI: 10.1371/journal.pone.0200268.].